Results 151 to 160 of about 187,247 (256)

[Colorectal neoplasms: Progress on the prevention, diagnosis, and therapy (discussion)].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007
Kentaro, Sugano, Tetsuya, Yano, Nobuyuki, Maatsuhashi, Shinei, Kudo, Aya, Kitamura   +4 more
openaire   +1 more source

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Abstract Irinotecan, a topoisomerase I inhibitor, is available as both non‐pegylated and pegylated formulations. The non‐pegylated formulation is licensed for use in advanced colorectal cancer either in combination with other agents or as monotherapy.
Dharmisha Chauhan, Cinzia Dello Russo, Jack Thompson, Dyfrig A. Hughes, Katherine Payne, Maria Tsakiroglou, Paul Ross, Rena Chauhan, Simon Jenkinson, Jessica Keen, Sophie Harding, Eleanor Lau, Michael Braun, Roshan Agarwal, Richard Adams, Elisabeth Rolf, Farah Al‐Sheikhli, Sarah Mitchell, Ruth Hammond, Rosie Roberts, Lorna Cairns, Shirley Heggarty, Janet Graham, Justin Mencel, Munir Pirmohamed   +24 more
wiley   +1 more source

Fecal <i>Cloacibacillus porcorum</i> Improves Non-Invasive Diagnosis of Colorectal Adenoma in the Hong Kong Population. [PDF]

Int J Mol Sci
Zeng Y, Lau EYT, Ye S, Lu J, Zhang R, Hu R, Liang JQ.   +6 more
europepmc   +1 more source

The performance of FIT-based colorectal cancer screening: results from a population-based program. [PDF]

Sci Rep
Shi J, Li Z, Liang D, Li D, He Y.
europepmc   +1 more source

Age-stratified risk profiles for emergency colorectal cancer resection: A machine-learning analysis. [PDF]

J Gastrointest Surg
Lal T, Liu F, Cabulong A, Kang CO, Hoehn RS, Rose J, Koroukian SM.   +6 more
europepmc   +1 more source

Pt‐TiO2 mesoporous nanosystem co‐delivering phlorezin enables synergistic sonodynamic‐chemoimmunotherapy for hepatocellular carcinoma via directly targeting DDX5 and metabolic reprogramming modulation

BMEMat, EarlyView.
Abstract Hepatocellular carcinoma (HCC), ranking as the third leading cause of cancer‐related mortality globally, continues to pose significant therapeutic challenges. Here, we developed an innovative nanosystem, Phl@PT, based on Pt‐TiO2 nanoparticles for the co‐delivery of Phlorezin, presenting a novel approach for HCC treatment through sonodynamic ...
Kairui Liu, Bo Zhang, Yue Wan, Zhiru Yang, Abdusami Abdurahman, Mengxin He, Shengtao Hu, Yi Zhang, Xiaoke Li, Jin Chang, Jun Kang, Liren Liu, Wanghua Liu, Shao Li   +13 more
wiley   +1 more source

Adenocarcinoma of the colon in a pediatric patient: a rare case report. [PDF]

J Surg Case Rep
Bibi F, Farhad A, Asif AE, Asif H, Shahid H, Sanan A, Zahra R, Hameed F, Tariq M, Shahid E, Ali MA, Singh JK, Sadat SH.   +12 more
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

A Rare Presentation of Cecal Adenocarcinoma Causing Adult Ileocolic Intussusception: A Case Report. [PDF]

Cureus
Fioletova M, Riemen N, Allsage T, Rauber R, Doty J.   +4 more
europepmc   +1 more source